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Abnormal respiratory drive in vibroacoustic disease
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Resumo
Enquadramento: As alterações do sistema nervoso
central em trabalhadores expostos a ruído de baixa
frequência (RBF, <500 Hz, incluindo infra-sons) fo-
ram observadas pela primeira vez há 25 anos, em téc-
nicos de aeronaves. Ao mesmo tempo, foi também
identificada patologia respiratória nos mesmos traba-
lhadores, mais tarde reproduzida em modelos animais
sob exposição a RBF. Actualmente, a doença vibroa-
cústica (VAD) define-se como patologia sistémica cau-
sada por exposição excessiva a RBF. O aparelho res-
piratório continua sob estudo intensivo, quer em
modelos humanos quer animais, expostos a excessivo
RBF, e tem sido confirmado como um alvo preferen-
cial do RBF. Uma vez que ambos os sistemas, respira-
tório e nervoso central, estão comprometidos nestes
trabalhadores, torna-se pertinente a investigação do
estado do controlo neurológico da respiração em doen-
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Abstract
Introduction: Central nervous system disorders in
workers exposed to low frequency noise (LFN, <500
Hz, including infrasound) were first observed 25 years
ago among aircraft technicians. Concurrently, respira-
tory pathology was identified in these workers, and
later reproduced in LFN-exposed animal models. To-
day vibroacoustic disease (VAD) is defined as the sys-
temic pathology caused by excessive exposure to LFN.
The respiratory tract continues to be under heavy scru-
tiny in both LFN-exposed humans and animal mo-
dels and has been confirmed as a major target for
LFN-induced damage. Given that both the respira-
tory and central nervous systems were compromised
in these workers, it became pertinent to investigate
the status of the neurological control of breathing in
VAD patients. Methods: The P-0.1 value, a measure
of  the suction pressure developed at the mouth 0.1
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tes com a VAD. O propósito deste estudo é a explo-
ração das implicações destes resultados. Métodos:
Avaliaram-se as pressões respiratórias máximas, in-
cluindo a pressão aos 0,100 seg de uma inspiração pro-
funda, com início na capacidade residual funcional
(P0.1), em respiração com ar ambiente, e também após
estabilização respiratória face à inalação de uma mistura
de ar com 5,9% de CO2 (Masterscreen versão 4.3, Via-
sys, Wurzburg, Alemanha), por válvula em Y com
oclusão – P0.1CO2. Foram observados 22 indivíduos
de sexo masculino, de 50,5 anos (± 8,5, entre 36-66
anos), expostos a nível ocupacional a ambientes ricos
em RBF. Também se avaliou um grupo de controlo,
de 7 indivíduos, exposto a menores níveis acumula-
dos de RBF, idade média 42,4 ±14, entre 25 e 61 anos.
Resultados: Os exames funcionais respiratórios fo-
ram normais, quer em doentes com VAD quer em
controlos. O índice de P0.1(CO2) (% do valor de refe-
rência) ficou muito abaixo em doentes com VAD (mé-
dia: 22,9%) relativamente ao grupo de controlo
(>60%). Conclusões: Na resposta reflexa ao acrésci-
mo de PCO2, os quimio-receptores centrais são res-
ponsáveis por 70% do estímulo ventilatório. Um estí-
mulo ventilatório diminuído pode traduzir certa
disfunção do tronco cerebral. Em doentes com VAD,
esta disfunção é corroborada por anomalias dos poten-
ciais evocados auditivos do tronco cerebral, bem como
por alterações detectáveis em ressonância magnética.
O índice P0.1CO2  pode revelar-se um indicador clínico
útil para o diagnóstico e seguimento da VAD. Em resu-
mo, o controlo neurológico da respiração está compro-
metido em doentes com VAD.
Rev Port Pneumol 2006; XII (4): 369-374
Palavras-chave: Ruído de baixa frequência, infra-sons,
controlo da respiração, P0.1CO2, pressões respiratórias
máximas.
seconds after the start of  inspiration, depends on the
respiratory centres and the autonomic nervous sys-
tem pathway of  the neural control of  respiratory func-
tion. By rebreathing CO2, (6% in air) normal indivi-
duals present an average seven-fold increase in
P0.1(CO2) as compared to basal P-0.1. Twenty-two male
VAD patients (ave. age 50.5±8.5 years, range: 36-66
years) underwent the P0.1(CO2) index respiratory dri-
ve tests, as well as standard pulmonary function tests.
Seven individuals (ave. age 42.4 ±14 years, range: 25-
61 years) with reduced LFN exposure served as con-
trols. Results: Pulmonary function tests were normal
in both VAD patients and controls. The P0.1(CO2) in-
dex was below average value in VAD patients (avera-
ge: 22.9%) while it presented normal values in the
control group (average >60%). Discussion: In the
involuntary response to increased PCO2 levels, cen-
tral chemoreceptors are responsible for 70% of  the
ventilatory stimulus. In VAD patients, this dysfunction
may originate in the brainstem. This is corroborated
by the fact that VAD patients register abnormal values
for auditory brainstem evoked potentials, and disclo-
se lesions with magnetic resonance imaging. The neu-
rological control of  breathing is compromised in VAD
patients. The P0.1(CO2) index may be a useful clinical
indicator for VAD diagnosis and follow-up.
Rev Port Pneumol 2006; XII (4): 369-374
Key-words: Low frequency noise, infrasound, respi-
ratory control, P0.1CO2, peak respiratory pressure.
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Introduction
Low frequency noise (LFN, <500 Hz, includ-
ing infrasound) is an agent of  disease that
can cause vibroacoustic disease (VAD), a
systemic pathology characterized by the ab-
normal growth of  extra-cellular matrices,
namely collagen and elastin1. In the early
1980s, auditory brainstem evoked potentials
(BAEP) were studied in VAD patients where
statistically significant delays in nerve con-
duction were identified2,3. Concurrently, res-
piratory pathology emerged as an important
feature in these patients4, and many aspects
have already been reproduced in LFN-ex-
posed animal models5.
The involuntary control of  ventilation is
mediated by the medullary inspiratory neu-
rons, modulated by inputs from two differ-
ent types of  chemoreptors. The peripheral
chemoreceptors, located in the carotid and
aortic bodies, provide input to the medul-
lary inspiratory neurons by detecting chang-
es in the partial pressure of  arterial carbon
dioxide (PCO2). The central chemoreceptors,
located in the medulla, are stimulated by the
changes in hydrogen-ion concentration [H+],
also as a consequence of  changes in the ar-
terial PCO2 
6.
Central chemoreceptors are responsible for
70%-80% of  the ventilatory stimulus, in-
duced by the reflex response to elevated
PCO2. This is because CO2 is a lipid-soluble
molecule that can rapidly diffuse across the
extra-cellular fluid that surrounds the chemo-
receptor. Medullary chemoreceptors respond
to an increased [H+], hence, an increased arte-
rial PCO2 regulates ventilation by changing
the [H+] (or pH)7.
There are two methods of  clinically assess-
ing the output of  the medullary respiratory
center8. With the rebreathing technique, a
small bag is filled with a low concentration
of CO2 (6-7% in air), and the patient re-
breathes into the bag over a period of  sever-
al minutes. PCO2 increases at a rate of  4-6
mm Hg and thus changes in ventilation can
be easily determined9.
Measurements of  the inspiratory pressure
(or suction) developed at the mouth 0.1
seconds after the start of  inspiration is
achieved by occlusion of  the airway du-
ring expiration, so that the first 0.1 second
of  the next inspiration is still against an
occluded airway (maintained for 0.5 sec-
onds). The pressure generated within the
first 0.1 seconds is considered to be a mea-
sure of  the total neural discharge of  the
respiratory centre8. The re-breathing tech-
nique does not make a distinction between
abnormalities in chest mechanics and
inadequacies of the neuronal control, while
the P0.1 technique is largely unaffected by
the mechanical properties, although it can
be influenced by lung volume.
Suspicion of  respiratory damage in LFN-
exposed workers began with four unusual
cases of  pleural effusion which did not res-
pond to therapy, had very prolonged re-
covery periods, and whose aetiology was
never identified10. This prompted, in 1992,
the first studies of LFN-exposed animal
models, where the respiratory tract epithe-
lia were examined with scanning and trans-
mission electron microscopy. Fibrosis of
the pleura, lung and trachea was identified,
along with destruction of  ciliary popula-
tions and fusion of  brush cell microvilli5.
Subsequent high-resolution CT scan of the
lung of  LFN-exposed workers, with and
without respiratory symptoms, disclosed
focal fibrosis and air-trapping4, among
other findings.
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Taking together the damage induced by LFN
exposure on the nervous and respiratory sys-
tems, it became pertinent to investigate the
condition of  the involuntary respiratory re-
flex, or respiratory drive, in LFN-exposed
individuals diagnosed with VAD.
Methods
Respiratory drive
Respiratory drive was calculated through CO2
sensitivity of  the P0,1 index, in resting condi-
tions, using a spirometer. The P-0.1 index is a
measure of  the pressure generated sponta-
neously in the early inspiratory effort, at the
end of  a forced expiration (see above). This
initial respiratory drive originates in the au-
tonomic (or involuntary) pathway of  the
neural control of  respiratory muscles. By
rebreathing CO2, normal individuals would
present a minimum six-fold increase in the
P0.1(CO2) value when compared to basal
(standard air) P-0.1 (Masterscreen 4.3, Viasys,
Jaeger, Wurzburg, Germany).
P0.1 measurements were obtained during
breathing of  standard air, and during breath-
ing of  air containing 5.9% CO2, via a Y-valve
with shutter – P0.1CO2. The ratio between
both measurements is an indicator of respi-
ratory drive. The best values between five
trials were chosen.
P0.1 measurements were always performed
first during air breathing. The patient ap-
proached the mouthpiece and was instruc-
ted to breath normally while the P0.1 curve
was registered. Then, connected to the CO2
bag circuit, the patient inspires from the
5.9% CO2 gas mixture. Patients with nor-
mal ventilatory drive show a clearly in-
creased tidal volume, breathing frequency
and ventilation, and after about 1-3 minutes
a steady state (stable) is reached. No such
ventilatory stability, hyperventilation state,
or unstable breathing level is obtained if
the patient has a disorder of  respiratory
drive. The P0.1 measurement with the 5.9%
CO2 gas mixture was then initiated, and the
P0.1CO2 value was registered after a mini-
mum 3-minute period of  CO2 breathing.
The shutter was activated endexpiratorily,
and the trial ended after about 10-15 occlu-
sions of  the shutter.
All subjects also underwent standard pulmo-
nary function tests.
Study population
This study encompasses to 22 male indivi-
duals, average age 50.5 years (± 8.5, range:
36-66 years). All were occupationally ex-
posed to LFN-rich environments, and all
had been diagnosed with VAD. All patients
were informed volunteers. Some were part
of  the initial VAD study group of  aircraft
technicians11, while others have approached
our group with complaints of  LFN-induced
pathology and have been diagnosed with
VAD12,13.
Within the context of  VAD studies, con-
trols are individuals who are not excessive-
ly exposed to LFN, and who are not diag-
nosed with VAD. Since pericardial
thickening in the absence of  an inflamma-
tory process and with no diastolic dysfunc-
tion is the hallmark of  VAD14, echocar-
diography is necessary to ascertain whether
an individual is an adequate control group
element. Age-matched control populations
have been fairly difficult to obtain. To date,
there is an insufficient number of  controls
to constitute a statistically robust compari-
son population (N=7, ave. age 42.4 ±14
years, range: 25-61). Hence, the values for
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the P0.1(CO2) values obtained for the study
group will be compared to the normal va-
lue provided by the manufacturer (Jaeger,
Germany), accepted as >60% of  reference,
corresponding to ± 2 standard deviations.
Although the authors are in the process of
obtaining the studies on which these values
are based directly from the manufacturer,
the comparison with manufacturer values,
as described, is not considered to be very
reliable, because no details are known re-
garding noise-exposure histories of  manu-
facturer control populations.
Results
Standard pulmonary function tests were nor-
mal in all 22 VAD patients. However, the
P0.1(CO2) values were significantly below
normal (60%): average: 25.6 % of  reference
(± 10.8%, range: 63%-6.3%).
Although insufficient in number (N=7), the
few elements already identified as controls
subjects have been disclosing P0.1(CO2) va-
lues similar to those quoted by the manufac-
turer as normal values, all reaching >60%.
Discussion
The P0.1(CO2) values reflect the neural out-
put of  the medullary respiratory center.
While this parameter could be altered due
to lung mechanical and functional impair-
ments, as standard lung function tests were
normal, this hypothesis is eliminated. The-
se results accordingly confirm that some
pathway(s) of  the involuntary control of
ventilation in VAD patients is severely
damaged. In these individuals, no hyper-
ventilation occurs in the presence of  air-
borne CO2. The P0.1(CO2) value does not
take into consideration individual varian-
ces of  lung volume. However, given the
extremely low indices obtained for the res-
piratory drive, it is supposed that indivi-
dual variations alone cannot account for
these pathological values.
Once again, the insidious nature of  LFN-
induced pathology is evidenced. Loss of
hyperventilatory function in the presence
of  an increased amount of  CO2 may bring
long-term consequences. In apnea divers,
this response is often impaired due to ex-
cessive exposure to increased levels of
PCO2. Apnea divers often have an increased
tolerance of  the medullary center to elec-
trolyte and local pH variations induced by
hypercapnia. Hypercapnia is usually well
tolerated in divers until the limit of  toxicity
after which, symptoms become evident. In
VAD patients, the PCO2 re-breathing test
is often uncomfortable. Some VAD patients
cannot tolerate the 5.6% CO2 mixture for
the minimum required 2 minute measure-
ment. Studies are underway to investigate
this feature in VAD patients.
The medullary centers, or central CO2-sen-
sitive areas (rostral, intermediate and caudal),
are located in the ventrolateral medulla, be-
tween the origins of  the 7th (facial) and 10th
(vagus) cranial nerves, and account for 70%
to 80% of  the CO2 induced increases in ven-
tilation. Brainstem damage has already been
identified in VAD through BAEP2,3 and
MRI11. Thus it would not be surprising if
the impairment of  the PCO2 response in
VAD patients was related to brainstem le-
sions. Within the scope of  VAD, this simple
and inexpensive test could serve as an indi-
cation of  brainstem damage, and could jus-
tify the prescription of more sophisticated
tests to ascertain the extent of  brainstem
damage.
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In accordance with data gathered to date,
it seems that the respiratory reflex is not
elicited during normal daily activities. In
the more common situation, an increase
in CO2
 is normally associated with a de-
crease of  O2, and/or an increase in CO.
Thus, the consequences of  not possess-
ing a functional neurological control of
breathing are not clearly understood. How-
ever, this cannot be equated with the situa-
tion of  respiratory acidosis, common in
severe COPD patients or hypoventila-
tion-obesity syndromes (obstructive ap-
nea-hypopnea).
The authors invite fellow scientists and phy-
sicians to perform this non-invasive and
inexpensive test on LFN-exposed individuals
they may have under their care.
Conclusions
The involuntary respiratory reflex, control-
led by brainstem respiratory centres, is im-
paired in VAD patients. This simple, non-
invasive and inexpensive diagnostic test
could become a mandatory test for confirm-
ing a VAD diagnosis but the lack of  a via-
ble control population impedes further con-
clusions on the usefulness of this medical
examination.
Acknowledgements
The authors would like to thank all patients
who have voluntarily contributed their time
to our studies.
Bibliography
1. Castelo Branco NAA, Alves-Pereira M. Vibroacoustic
disease. Noise & Health 2004; 6(23):3-20.
2. Castelo Branco MSN, Castelo Branco NAA, Entrudo
A, Marvão J. A standardization method of  the brains-
tem auditory evoked potentials. J Soc Ciências Med.
Lisboa 1985; 149:214-20.
3. Marvão JH, Castelo Branco MSN, Entrudo A, Caste-
lo Branco NAA. Changes of  the brainstem auditory evo-
ked potentials induced by occupational vibration. J Soc
Ciências Med 1985; 149:478-486. (Recipient of  the 1984
Ricardo Jorge National Public Health Award.)
4. Reis Ferreira JM, Couto AR, Jalles-Tavares N, Castelo
Branco MSN, Castelo Branco NAA. Airflow limitations
in patients with vibroacoustic disease. Aviat Space Envi-
ron Med 1999; 70 (3, Suppl):A63-9.
5. Castelo Branco NAA, Alves-Pereira M, Martins dos
Santos J, Monteiro E. SEM and TEM study of  rat respi-
ratory epithelia exposed to low frequency noise. In:
Science and Technology Education in Microscopy: An
Overview, A. Mendez-Vilas (Ed.), Formatex: Badajoz,
Spain, 2002; Vol. II:505-33.
6. Cunningham DJC. The control system regulating bre-
athing in man. Quarterly Rev Biophy 1974; 6:433-83.
7. West JB. Respiratory Physiology. Williams & Wilkins,
Baltimore, MD, USA, 1995.
8. West JB. Pulmonary Pathology. Williams & Wilkins,
Baltimore, MD, USA, 1997.
9. Read DJ. A clinical method for assessing the ventila-
tory response to carbon dioxide. Austr Ann Med 1976;
16:20-32.
10. Castelo Branco NAA, Rodriguez Lopez E. The vi-
broacoustic disease – An emerging pathology. Aviat Spa-
ce Environ Med 1999; 70(3, Suppl):A1-6.
11. Pimenta MG, Martinho Pimenta AJF, Castelo Bran-
co MSN, Castelo Branco NAA. ERP P300 and brain
magnetic resonance imaging in patients with vibroacous-
tic disease. Aviat Space Environ Med 1999; 70(3,
Suppl):A107-14.
12. Arnot JW. Vibroacoustic disease I: The personal ex-
perience of  a motorman. Inst Acoustics (U.K.) 2003;
25(Pt 2):66-71.
13. Monteiro MB, Reis Ferreira J, Mendes CP, Alves-Pe-
reira M, Castelo Branco NAA. Vibroacoustic disease and
respiratory pathology III – Tracheal and bronchial lesi-
ons. Proc Internoise 2004, Prague, Czech Republic, Au-
gust 22-25: No. 638 (5 pages).
14. Holt BD. The pericardium. In: Hurst’s The Heart, V.
Furster, R. Wayne Alexander, & F. Alexander, (Eds.),
McGraw-Hill Professional Publishing, New York, 2001;
2061-82.
Drive respiratório anormal na doença vibroacústica
José Reis Ferreira, José Albuquerque e Sousa, Peter Foreid, Marco Antunes, Sofia Cardoso, Mariana Alves-Pereira, Nuno A A Castelo Branco
Pneumologia 12-4 - Miolo 3.pmd 04-08-2006, 9:46374
